Ilaria Fuso Nerini Marta Cesca Francesca Bizzaro Raffaella Giavazzi
Defeating cancer:the 150 most impo
Chao-Nan Qian Wei Zhang Rui-Hua Xu
Development and validation of a no
Wenhua Liang Guanzhu Shen Yaxiong Zhang Gang Chen Xuan Wu Yang Li Anchuan Li Shiyang Kang Xi Yuan Xue Hou Peiyu Huang Yan Huang Hongyun Zhao Ying Tian Chong Zhao Li Zhang
MicroRNA-506 is up-regulated in th
Run-Fen Cheng Jian Wang Jing-Yi Zhang Lin Sun Yan-Rui Zhao Zhi-Qiang Qiu Bao-Cun Sun Yan Sun
Prognostic factors and failure pat
Yan-Ping Mao Ling-Long Tang Lei Chen Ying Sun Zhen-Yu Qi Guan-Qun Zhou Li-Zhi Liu Li Li Ai-Hua Lin Jun Ma
The clinical association of progra
John Zeng Hong Li Wei Gao Wai-Kuen Ho Wen Bin Lei William Ignace Wei Jimmy Yu-Wai Chan Thian-Sze Wong
Phase Ⅱ open-label study of recomb
Yun Leng Lugui Qiu Jian Hou Yaozhong Zhao Xuejun Zhang Shifang Yang Hao Xi Zhongxia Huang Ling Pan Wenming Chen
ABO blood group is a predictor of
Ting Jin Pei-Jing Li Xiao-Zhong 論文QQ81995535 Chen Wei-Han Hu
New risk factors and new tendency
Qing-Qing Cai Li-Yang Hu Qi-Rong Geng Jie Chen Zhen-Hai Lu Hui-Lan Rao Qing Liu Wen-Qi Jiang Hui-Qiang Huang Tong-Yu Lin Zhong-Jun Xia
Prognostic value and predictive th
Yu-Xiang He Ying Wang Peng-Fei Cao Lin Shen Ya-Jie Zhao Zi-Jian Zhang Deng-Ming Chen Tu-Bao Yang Xin-Qiong Huang Zhou Qin You-Yi Dai Liang-Fang Shen
Study protocol of the Asian XELIRI
Masahito Kotaka Ruihua Xu Kei Muro Young Suk Park Satoshi Morita Satoru Iwasa Hiroyuki Uetake Tomohiro Nishina Hiroaki Nozawa Hiroshi Matsumoto Kentaro Yamazaki Sae-Won Han Wei Wang Joong Bae Ahn Yanhong Deng Sang-Hee Cho Yi Ba Keun-Wook Lee Tao Zhang Taroh Satoh Marc E.Buyse Baek-Yeol Ryoo Lin Shen Junichi Sakamoto Tae Won Kim
Phase Ⅰ/Ⅱ trial evaluating concurr
Lin Kong Jing Gao Jiyi Hu Weixu Hu Xiyin Guan Rong Lu Jiade J.Lu
.jpg)
